Detrimental Effect of Natural Killer Cell Alloreactivity in T-replete Hematopoietic Cell Transplantation (HCT) for Leukemia Patients

Biology of Blood and Marrow Transplantation

Volumn 13, Issue 2, 2007, Pages 197-205

  Sun, Joel Y ^a   Dagis, Andrew ^a   Gaidulis, Laima ^a   Miller, Marcia M ^a   Rodriguez, Roberto ^a   Parker, Pablo ^a   Nademanee, Auayporn ^a   Falk, Peter ^b   Rosenthal, Joseph ^a   Forman, Stephen J ^a   Senitzer, David ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b Kaiser Regional BMT Program   (United States)

Author keywords

Clinical outcomes; Hematopoietic cell transplantation; Killer immunoglobulin like receptors; Natural killer cells

Indexed keywords

CYCLOSPORIN A; HLA ANTIGEN CLASS 1; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; METHOTREXATE; STEROID; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER RELAPSE; CHILD; CHRONIC MYELOID LEUKEMIA; CLINICAL OBSERVATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; MAJOR CLINICAL STUDY; MYELODYSPLASTIC SYNDROME; NATURAL KILLER CELL; OVERALL SURVIVAL; RISK ASSESSMENT; T CELL DEPLETION;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INFANT; KILLER CELLS, NATURAL; LEUKEMIA; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; RECEPTORS, IMMUNOLOGIC; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS;

EID: 33846292943     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.09.009     Document Type: Article

References (41)

1. Farag S.S., and Caligiuri M.A. Human natural killer cell development and biology. Blood Rev 20 (2006) 123-137
2. Moretta A. The dialogue between human natural killer cells and dendritic cells. Curr Opin Immunol 17 (2005) 306-311
3. Walzer T., Dalod M., Robbins S.H., Zitvogel L., and Vivier E. Natural-killer cells and dendritic cells: "l'union fait la force.". Blood 106 (2005) 2252-2258
4. Passweg J.R., Stern M., Koehl U., Uharek L., and Tichelli A. Use of natural killer cells in hematopoetic stem cell transplantation. Bone Marrow Transplant 35 (2005) 637-643
5. Ruggeri L., Capanni M., Mancusi A., Martelli M.F., and Velardi A. The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation. Transpl Immunol 14 (2005) 203-206
6. Marsh S.G., Parham P., Dupont B., et al. Killer-cell immunoglobulin-like receptor (KIR) nomenclature report, 2002. Hum Immunol 64 (2003) 648-654
7. Norman P.J., and Parham P. Complex interactions: the immunogenetics of human leukocyte antigen and killer cell immunoglobulin-like receptors. Semin Hematol 42 (2005) 65-75
8. Uhrberg M. Shaping the human NK cell repertoire: an epigenetic glance at KIR gene regulation. Mol Immunol 42 (2005) 471-475
9. Bignon J.D., and Gagne K. KIR matching in hematopoietic stem cell transplantation. Curr Opin Immunol 17 (2005) 553-559
10. Witt C.S., and Christiansen F.T. The relevance of natural killer cell human leukocyte antigen epitopes and killer cell immunoglobulin-like receptors in bone marrow transplantation. Vox Sang 90 (2006) 10-20
11. Hsu K.C., Keever-Taylor C.A., Wilton A., et al. Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes. Blood 105 (2005) 4878-4884
12. Leung W., Iyengar R., Triplett B., et al. Comparison of killer Ig-like receptor genotyping and phenotyping for selection of allogeneic blood stem cell donors. J Immunol 174 (2005) 6540-6545
13. Ruggeri L., Capanni M., Urbani E., et al. Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants. Science 295 (2002) 2097-2100
14. Giebel S., Locatelli F., Lamparelli T., et al. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors. Blood 102 (2003) 814-819
15. Beelen D.W., Ottinger H., Ferencik S., et al. Genotypic inhibitory killer immunoglobulin-like receptor ligand incompatibility enhances the long-term antileukemic effect of unmodified allogeneic hematopoietic stem cell transplantation in patients with myeloid leukemias. Blood 105 (2005) 2594-2600
16. Davies S.M., Ruggieri L., DeFor T., et al. Evaluation of KIR ligand incompatibility in mismatched unrelated donor hematopoietic transplants. Killer immunoglobulin-like receptor. Blood 100 (2002) 3825-3827
17. De Santis D., Bishara A., Witt C.S., et al. Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants. Tissue Antigens 65 (2005) 519-528
18. Schaffer M., Aldener-Cannava A., Remberger M., Ringden O., and Olerup O. Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation. Tissue Antigens 62 (2003) 243-250
19. Schaffer M., Malmberg K.J., Ringden O., Ljunggren H.G., and Remberger M. Increased infection-related mortality in KIR-ligand-mismatched unrelated allogeneic hematopoietic stem-cell transplantation. Transplantation 78 (2004) 1081-1085
20. Malmberg K.J., Schaffer M., Ringden O., Remberger M., and Ljunggren H.G. KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation. Mol Immunol 42 (2005) 531-534
21. Bornhauser M., Schwerdtfeger R., Martin H., Frank K.H., Theuser C., and Ehninger G. Role of KIR ligand incompatibility in hematopoietic stem cell transplantation using unrelated donors. Blood 103 (2004) 2860-2861
22. Bishara A., De Santis D., Witt C.C., et al. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD. Tissue Antigens 63 (2004) 204-211
23. Cook M.A., Milligan D.W., Fegan C.D., et al. The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia. Blood 103 (2004) 1521-1526
24. Giebel S., Locatelli F., Wojnar J., et al. Homozygosity for human leucocyte antigen-C ligands of KIR2DL1 is associated with increased risk of relapse after human leucocyte antigen-C-matched unrelated donor haematopoietic stem cell transplantation. Br J Haematol 131 (2005) 483-486
25. Farag S., Bacigalupo A., Dupont B., et al. The effect of killer immunoglobulin-like receptor (KIR) ligand incompatibility on outcome of unrelated donor bone marrow transplantation (UDT). Blood 104 (2004) 127a Abstract 434
26. Witt C.S., and Christiansen F.T. The relevance of natural killer cell human leucocyte antigen epitopes and killer cell immunoglobulin-like receptors in bone marrow transplantation. Vox Sang 90 (2006) 10-20
27. Hsu K.C., Gooley T., Malkki M., et al. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy. Biol Blood Marrow Transplant 12 (2006) 828-836
28. Sun J.Y., Gaidulis L., Miller M.M., et al. Development of a multiplex PCR-SSP method for killer-cell immunoglobulin-like receptor genotyping. Tissue Antigens 64 (2004) 462-468
29. Przepiorka D., Weisdorf D., Martin P., et al. 1994 Consensus conference on acute GVHD grading. Bone Marrow Transplant 15 (1995) 825-828
30. Denis L., Sivula J., Gourraud P.A., et al. Genetic diversity of KIR natural killer cell markers in populations from France, Guadeloupe, Finland, Senegal and Reunion. Tissue Antigens 66 (2005) 267-276
31. Sun J.Y., Gaidulis L., Dagis A., et al. Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML. Bone Marrow Transplant 36 (2005) 525-530
32. Uhrberg M., Parham P., and Wernet P. Definition of gene content for nine common group B haplotypes of the Caucasoid population: KIR haplotypes contain between seven and eleven KIR genes. Immunogenetics 54 (2002) 221-229
33. Lowe E.J., Turner V., Handgretinger R., et al. T-cell alloreactivity dominates natural killer cell alloreactivity in minimally T-cell-depleted HLA-non-identical paediatric bone marrow transplantation. Br J Haematol 123 (2003) 323-326
34. Cooley S., McCullar V., Wangen R., et al. KIR reconstitution is altered by T cells in the graft and correlates with clinical outcomes after unrelated donor transplantation. Blood 106 (2005) 4370-4376
35. Nguyen S., Dhedin N., Vernant J.P., et al. NK-cell reconstitution after haploidentical hematopoietic stem-cell transplantations: immaturity of NK cells and inhibitory effect of NKG2A override GvL effect. Blood 105 (2005) 4135-4142
36. Shilling H.G., Young N., Guethlein L.A., et al. Genetic control of human NK cell repertoire. J Immunol 169 (2002) 239-247
37. Huang Y., Rezzoug F., Xu H., et al. NK cells play a critical role in the regulation of class I-deficient hemopoietic stem cell engraftment: evidence for NK tolerance correlates with receptor editing. J Immunol 175 (2005) 3753-3761
38. Johansson S., Johansson M., Rosmaraki E., et al. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J Exp Med 201 (2005) 1145-1155
39. Kim S., Poursine-Laurent J., Truscott S.M., et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436 (2005) 709-713
40. Lafarge X., Pitard V., Ravet S., et al. Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of gammadelta T cells. Eur J Immunol 35 (2005) 1896-1905
41. Xu J., Vallejo A.N., Jiang Y., Weyand C.M., and Goronzy J.J. Distinct transcriptional control mechanisms of killer immunoglobulin-like receptors in natural killer (NK) and in T cells. J Biol Chem 280 (2005) 24277-24285